Exciva is a series a startup based in Germany. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Exciva is a clinical-stage biopharmaceutical company developing a therapeutic compound for treating agitation and aggression in Alzheimer’s disease.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky